(VIANEWS) - Sculptor Capital Management (SCU), Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest (PHD), Columbia Seligman Premium Technology Growth Fund (STK) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Sculptor Capital Management (SCU) | 23.22 | -2.07% | 11.18% | 2021-07-15 01:44:05 |
| 2 | Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest (PHD) | 11.86 | -0.59% | 6.29% | 2021-07-14 22:43:04 |
| 3 | Columbia Seligman Premium Technology Growth Fund (STK) | 33.82 | 0.33% | 5.49% | 2021-07-15 03:09:06 |
| 4 | Gilead Sciences (GILD) | 68.63 | 0.48% | 4.26% | 2021-07-16 15:08:42 |
| 5 | Nuveen California Dividend Advantage Municipal Fund (NAC) | 16.05 | 0.4% | 4.09% | 2021-07-14 19:10:06 |
| 6 | The Blackstone Group (BX) | 102.20 | -0.29% | 3.05% | 2021-07-16 15:37:18 |
| 7 | Farmers National Banc Corp. (FMNB) | 15.41 | 1.31% | 2.61% | 2021-07-16 00:13:08 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Sculptor Capital Management (SCU) - Dividend Yield: 11.18%
Sculptor Capital Management, Inc. is a publicly owned hedge fund sponsor. The firm provides investment advisory services to its clients. It primarily caters to institutional investors, which include pension funds, fund-of-funds, foundations and endowments, corporations and other institutions, private banks and family offices. The firm also manages separate client-focused equity, fixed income, and real estate separate accounts. It also manages commingled funds and specialized products. The firm invests in equity, fixed income and real estate markets across the world. It employs quantitative and qualitative analysis to make its investments through a combination of fundamental bottom-up research, a high degree of flexibility, and integrated risk management. For its multi-strategy portfolios, the firm employs strategies like convertible and derivative arbitrage, corporate credit, long/short equity special situations, buyout investments, merger arbitrage, private investments, and structured credit. It also invests in real estate and traditional real estate assets including multifamily, office, hotel and retail, loans, portfolio acquisitions, loan pools, operating companies, structured debt products, public securities, and non-traditional real estate assets including gaming, distressed land and residential, cell towers, parking, golf, debt and senior housing. For private equity investments, it considers investments in a variety of special situations that seek to realize value through strategic sales or initial public offerings. The firm was previously known as Och-Ziff Capital Management Group Inc. Sculptor Capital Management, Inc. was founded in 1994 and is based New York, New York.
Volume
Today's last reported volume for Sculptor Capital Management is 267135, 85.93% above its average volume of 143672.
Sculptor Capital Management's last close was $25.93, 4.35% below its 52-week high of $27.11.
The company's growth estimates for the ongoing quarter is 130.2% and a drop 15.4% for the next.Sculptor Capital Management's Revenue
Year-on-year quarterly revenue growth grew by 55.7%, now sitting on 941.14M for the twelve trailing months.
Sculptor Capital Management's Stock Yearly Top and Bottom Value
Sculptor Capital Management's stock is valued at $23.22 at 18:15 EST, way below its 52-week high of $27.11 and way higher than its 52-week low of $10.28.
Sculptor Capital Management's Moving Average
Sculptor Capital Management's value is below its 50-day moving average of $24.82 and higher than its 200-day moving average of $21.88.More news about Sculptor Capital Management.
2. Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest (PHD) - Dividend Yield: 6.29%
Pioneer Floating Rate Trust is closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the Barclays U.S. High Yield Loans Index. Pioneer Floating Rate Trust was formed on October 6, 2004 and is domiciled in the United States.
Volume
Today's last reported volume for Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest is 37372, 20.64% below its average volume of 47091.
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's last close was $11.29, 6.69% below its 52-week high of $12.10.
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's Revenue
Year-on-year quarterly revenue growth declined by 6.7%, now sitting on 23.75M for the twelve trailing months.
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's Stock Yearly Top and Bottom Value
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's stock is valued at $11.86 at 18:15 EST, below its 52-week high of $12.10 and way higher than its 52-week low of $9.36.
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's Moving Average
Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest's value is higher than its 50-day moving average of $11.71 and higher than its 200-day moving average of $11.20.More news about Pioneer Floating Rate Trust Pioneer Floating Rate Trust Shares of Beneficial Interest.
3. Columbia Seligman Premium Technology Growth Fund (STK) - Dividend Yield: 5.49%
Columbia Seligman Premium Technology Growth Fund is a closed ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC. It invests in public equity markets. The fund seeks to invest in stocks of companies operating in the technology sector. It primarily invests in growth stocks of companies. It employs fundamental analysis with focus on factors like companies that have best growth prospects, trade at attractive valuations and deliver solid investment returns over time to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P North American Technology Sector Index. The fund was formerly known as Seligman Premium Technology Growth Fund, Inc. Columbia Seligman Premium Technology Growth Fund was formed on November 30, 2009 and is domiciled in the United States.
Volume
Today's last reported volume for Columbia Seligman Premium Technology Growth Fund is 42342, 19.64% below its average volume of 52693.
Columbia Seligman Premium Technology Growth Fund's last close was $34.57, 4.19% under its 52-week high of $36.08.
Columbia Seligman Premium Technology Growth Fund's Stock Yearly Top and Bottom Value
Columbia Seligman Premium Technology Growth Fund's stock is valued at $33.82 at 18:15 EST, below its 52-week high of $36.08 and way above its 52-week low of $20.90.
Columbia Seligman Premium Technology Growth Fund's Moving Average
Columbia Seligman Premium Technology Growth Fund's value is below its 50-day moving average of $34.89 and higher than its 200-day moving average of $31.75.More news about Columbia Seligman Premium Technology Growth Fund.
4. Gilead Sciences (GILD) - Dividend Yield: 4.26%
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California.
Volume
Today's last reported volume for Gilead Sciences is 5434370, 21.26% below its average volume of 6901720.
Gilead Sciences's last close was $68.30, 13.48% below its 52-week high of $78.94.
The company's growth estimates for the current quarter is 56.8% and a drop 20.9% for the next.Gilead Sciences's Revenue
Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 25.56B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Gilead Sciences's stock is considered to be overbought (>=80).
Gilead Sciences's Stock Yearly Top and Bottom Value
Gilead Sciences's stock is valued at $68.63 at 18:15 EST, way below its 52-week high of $78.94 and way above its 52-week low of $56.56.
Gilead Sciences's Moving Average
Gilead Sciences's worth is higher than its 50-day moving average of $67.66 and above its 200-day moving average of $65.60.More news about Gilead Sciences.
5. Nuveen California Dividend Advantage Municipal Fund (NAC) - Dividend Yield: 4.09%
Nuveen California Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California, United States. The fund invests in undervalued municipal securities and other related investments that are exempt from regular federal and California income taxes. It primarily invests in securities that are rated Baa or BBB or better by Moody's Investors Service, Inc. or Standard & Poor's, and have an average maturity of 20.96 years. The fund employs fundamental analysis with a bottom-up approach to create its portfolio. It benchmarks the performance of its portfolio against the Standard & Poor's (S&P) California Municipal Bond Index and Standard & Poor's (S&P) National Municipal Bond Index. The fund was formerly known as Nuveen California Dividend Advantage Municipal Fund. Nuveen California Quality Municipal Income Fund was formed on December 1, 1998 and is domiciled in the United States.
Volume
Today's last reported volume for Nuveen California Dividend Advantage Municipal Fund is 163387, 9.59% above its average volume of 149092.
Nuveen California Dividend Advantage Municipal Fund's last close was $15.48, 4.56% under its 52-week high of $16.22.
Nuveen California Dividend Advantage Municipal Fund's Revenue
Year-on-year quarterly revenue growth declined by 15%, now sitting on 130.93M for the twelve trailing months.
Nuveen California Dividend Advantage Municipal Fund's Stock Yearly Top and Bottom Value
Nuveen California Dividend Advantage Municipal Fund's stock is valued at $16.05 at 18:15 EST, under its 52-week high of $16.22 and way above its 52-week low of $14.36.
Nuveen California Dividend Advantage Municipal Fund's Moving Average
Nuveen California Dividend Advantage Municipal Fund's worth is above its 50-day moving average of $15.71 and above its 200-day moving average of $15.18.More news about Nuveen California Dividend Advantage Municipal Fund.
6. The Blackstone Group (BX) - Dividend Yield: 3.05%
The Blackstone Group Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services. The real estate segment specializes in opportunistic, core+ investments as well as debt investment opportunities collateralized by commercial real estate, and stabilized income-oriented commercial real estate across North America, Europe and Asia. The firm's corporate private equity business pursues transactions throughout the world across a variety of transaction types, including large buyouts, mid-cap buyouts, buy and build platforms, which involves multiple acquisitions behind a single management team and platform, and growth equity/development projects involving significant minority investments in operating companies and greenfield development projects in energy and power, financial services, healthcare, life sciences, enterprise tech and consumer, as well as consumer technologies. Its hedge fund business manages a broad range of commingled and customized fund solutions and its credit business focuses on loans, and securities of non-investment grade companies spread across the capital structure including senior debt, subordinated debt, preferred stock and common equity. The Blackstone Group Inc. was founded in 1985 and is headquartered in New York, New York with additional offices across Asia, Europe and North America.
Volume
Today's last reported volume for The Blackstone Group is 3365360, 18.76% below its average volume of 4142400.
The Blackstone Group's last close was $102.50, 0.72% under its 52-week high of $103.24.
The Blackstone Group's Sales
The Blackstone Group's sales growth is 61.7% for the current quarter and 28.6% for the next. The company's growth estimates for the present quarter and the next is 76.7% and 30.2%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,The Blackstone Group's stock is considered to be overbought (>=80).
The Blackstone Group's Stock Yearly Top and Bottom Value
The Blackstone Group's stock is valued at $102.20 at 18:15 EST, under its 52-week high of $103.24 and way higher than its 52-week low of $49.26.
The Blackstone Group's Moving Average
The Blackstone Group's value is above its 50-day moving average of $96.88 and way higher than its 200-day moving average of $80.12.More news about The Blackstone Group.
7. Farmers National Banc Corp. (FMNB) - Dividend Yield: 2.61%
Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries. It offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit, night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, MasterCard and Visa credit cards, brokerage, and other services. The company also provides personal and corporate trust services in the areas of estate settlement, trust administration, and employee benefit plans; retirement services; property and casualty insurance products and services; and various insurance products through licensed representatives, as well as invests in municipal securities. It operates through 39 locations in northeastern region of Ohio and two-branch locations in southwestern Pennsylvania. The company was founded in 1887 and is headquartered in Canfield, Ohio.
Volume
Today's last reported volume for Farmers National Banc Corp. is 53027, 34.47% below its average volume of 80917.
Farmers National Banc Corp.'s last close was $17.40, 4.71% under its 52-week high of $18.26.
The company's growth estimates for the present quarter and the next is 10.3% and 2.6%, respectively.Farmers National Banc Corp.'s Revenue
Year-on-year quarterly revenue growth grew by 31.2%, now sitting on 133.1M for the twelve trailing months.
Farmers National Banc Corp.'s Stock Yearly Top and Bottom Value
Farmers National Banc Corp.'s stock is valued at $15.41 at 18:15 EST, way under its 52-week high of $18.26 and way higher than its 52-week low of $10.05.
Farmers National Banc Corp.'s Moving Average
Farmers National Banc Corp.'s worth is below its 50-day moving average of $16.40 and under its 200-day moving average of $15.64.More news about Farmers National Banc Corp..